The World Health Organization reports that cancer is the primary cause of one out of every six deaths. This devastating medical condition occurs when there are abnormal cellular developments throughout the body, usually due to genetic alterations.
Though cancer is a serious problem nowadays, advances in ways to treat it have been rather gradual. Surgery, radiotherapy, and chemotherapy are still the core treatments. Chemotherapy in particular might be an effective medication for the treatment of widespread cancer rather than radiotherapy or surgery.
Most cancer treatments have a lot of unpleasant outcomes because they harm healthy cells as well. Additionally, treatments can be quite costly financially and take a lot of time to make. It is fairly common for doctors to find or recognize new uses for medicines that have already been approved, for instance, taking a small amount of aspirin every day to reduce the risk of a heart attack.
It appears that several existing medications have been found to possess anticancer properties when employed by those diagnosed with cancer. According to clinical researchers, these findings could not only elevate the efficacy of cancer treatment, but may also reduce the amount of time needed to develop fresh cancer-fighting medications. This hopeful hypothesis is seen to be true in the example of a dog anthelmintic medication.
Fenbendazole, a drug used to treat worm infestations, may have potential in treating cancer.
Fenbendazole is a frequently used anthelmintic/antiparasitic medicine in veterinary practice. Interestingly, the canine dewormer fermandazole can be used to treat parasites and hookworms, but even more remarkable is that research undertaken by Joe Tippens has revealed that it can also be used to combat cancer. Yes, you heard right – a medication that is typically employed to rid dogs of parasites is being tested as a drug to fight cancer.
Since Joe Tippens’ remarkable story of overcoming a serious ailment, fenbendazole has been a major point of debate in medical circles. Accounts of people succeeding in treating cancer with fenbendazole have been all over on cancer websites and blogs. While some are suspicious of using fenbendazole on people to try to cure cancer, others are taking up the same treatment plan as Joe.
Joe Tippens’ technique includes taking fenbendazole, tumeric, CBD oil, and vitamin E. Vitamin E is not necessary; presently, the two most essential parts of the procedure are turmeric and CBD oil.
Is it safe for humans to take dog deworming medication?
People often question whether a medication intended for dogs can be safely taken by humans. Studies indicate that fenbendazole, normally used as a dog dewormer, is safe for people with few adverse reactions occurring. Research about fenbendazole for use in humans found that the drug is deemed safe for a broad range of animals, humans included. These investigations also uncovered that fenbendazole may participate in the destroying of cancer cells, potentially allowing for eventual treatments of this disease. It can do so by inducing apoptosis (programmatic cell death). This means repurposing a drug originally intended to treat dogs may be a valid solution to treat human cancer.
What is the time frame for fenbendazole to become effective?
Fenbendazole, a dewormer initially intended for dogs that is now being used as a cancer treatment in humans, prevents the growth and spread of cancer by disrupting the creation of microtubules. This protein plays an essential role in many cellular activities, particularly in rapidly reproducing cells like cancer cells, which require microtubules for cell architecture, transporting nutrients, and synthesizing DNA. By inhibiting microtubule formation, fenbendazole can inhibit the rapid division of cancer cells and thus stop the growth of cancer in the body.
It has long been known that several cancer treatments, including vinca alkaloids, paclitaxel, and docetaxel, target microtubules. These drugs stop the spread of cancer by blocking the movement of microtubules, which are essential for dividing DNA. However, a recent discovery has revealed that fenbendazole (a dog dewormer) has less of an impact on microtubules, when compared to other treatments like nocodazole and colchicine. This explains why fenbendazole is much less dangerous than other chemotherapy drugs.
It appears that unlike traditional chemotherapy drugs, fenbendazole had no effect on glycoprotein expression in humans. Therefore, this provides a positive outcome in the fight against cancer, since there is less chance for the cancer cells to become resistant to the treatment. Results from this study suggest that fenbendazole could be beneficial in the long-term cancer treatment, as drug resistance is less likely to occur, compared to other therapies.
The most recent research on cancer cells indicates that after 32 hours of engaging with the canine dewormer, fenbendazole, up to 30% of cancer cells were killed. This study was focused on the particularly invasive type of cancer, non-small cell lung carcinoma (NSCLC) and took days in lab settings to observe its effects. However, if people were to use fenbendazole, it could take several weeks or months to start noticing significant improvements.